LONDON, Oct. 9 /PRNewswire-FirstCall/ -- SkyePharma PLC today announces that it has appointed John Murphy as Company Secretary.
John is a lawyer with extensive experience in legal and company secretarial roles in listed pharmaceutical and biotechnology companies including Medeva, Celltech and Pharmagene. John joined SkyePharma on 1st March this year as General Counsel and will be combining both roles in the Company.
For further information please contact: SkyePharma PLC Frank Condella, Chief Executive Officer +44 207 491 1777 Ken Cunningham, Chief Operating Officer Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000 Tim Anderson / Mark Court / Rebecca Skye Dietrich The Trout Group Seth Lewis +1 617 583 1308 About SkyePharma
SkyePharma PLC develops pharmaceutical products benefiting from world- leading drug delivery technologies that provide easier-to-use and more effective drug formulations. There are now twelve approved products incorporating SkyePharma’s technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit http://www.skyepharma.com.
SkyePharma PLC
CONTACT: Frank Condella, Chief Executive Officer, or Ken Cunningham, ChiefOperating Officer, both of SkyePharma PLC, +44-207-491-1777; SandraHaughton, US Investor Relations, +1-212-753-5780; or Tim Anderson, or MarkCourt, or Rebecca Skye Dietrich, all of Buchanan Communications,+44-207-466-5000; or Seth Lewis of The Trout Group, +1-617-583-1308
Web site: http://www.skyepharma.com/
